주식회사 셀인셀즈

{
  "address": "서울특별시 종로구",
  "ceo_name": "조재진",
  "certificate": [
    {
      "cert_number": "20160112751",
      "changes": "",
      "disclosure_date": "2016-11-11",
      "first_cert_date": "2016-11-11",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-11-11 ~ 2018-11-10"
    },
    {
      "cert_number": "20190100508",
      "changes": "",
      "disclosure_date": "2019-01-22",
      "first_cert_date": "2016-11-11",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-11-11 ~ 2020-11-10"
    },
    {
      "cert_number": "20200114445",
      "changes": "",
      "disclosure_date": "2020-11-09",
      "first_cert_date": "2016-11-11",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-11-11 ~ 2022-11-10"
    },
    {
      "cert_number": "20221117010017",
      "changes": "",
      "disclosure_date": "2022-11-17",
      "first_cert_date": "2016-11-11",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-11-11 ~ 2025-11-10"
    },
    {
      "cert_number": "20251209010004",
      "changes": "",
      "disclosure_date": "2025-12-09",
      "first_cert_date": "2016-11-11",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-11-11 ~ 2028-11-10"
    }
  ],
  "company_name": "주식회사 셀인셀즈",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 6884825000,
      "cost_of_sales": 0,
      "current_assets": 5441507000,
      "current_liabilities": 18871999000,
      "gross_profit": 29000000,
      "net_income": -7365389000,
      "net_income_bs": -7365389000,
      "non_current_assets": 2723172000,
      "non_current_liabilities": 1259270000,
      "non_operating_expenses": 3229688000,
      "non_operating_income": 137997000,
      "operating_profit": -4273698000,
      "revenue": 29000000,
      "sga_expenses": 4302698000,
      "total_assets": 8164679000,
      "total_equity": -11966590000,
      "total_liabilities": 20131269000
    },
    "2023": {
      "capital_stock": 9825588000,
      "cost_of_sales": 0,
      "current_assets": 5355479000,
      "current_liabilities": 22963258000,
      "gross_profit": 23500000,
      "net_income": -9624972000,
      "net_income_bs": -9624972000,
      "non_current_assets": 2602426000,
      "non_current_liabilities": 1132764000,
      "non_operating_expenses": 4439244000,
      "non_operating_income": 196347000,
      "operating_profit": -5382075000,
      "revenue": 23500000,
      "sga_expenses": 5405575000,
      "total_assets": 7957905000,
      "total_equity": -16138117000,
      "total_liabilities": 24096022000
    },
    "2024": {
      "capital_stock": 11431955000,
      "cost_of_sales": 0,
      "current_assets": 1694358000,
      "current_liabilities": 20523172000,
      "gross_profit": 14200000,
      "net_income": -3388205000,
      "net_income_bs": -3388205000,
      "non_current_assets": 2108895000,
      "non_current_liabilities": 1002968000,
      "non_operating_expenses": 1689081000,
      "non_operating_income": 3928112000,
      "operating_profit": -5627236000,
      "revenue": 14200000,
      "sga_expenses": 5641436000,
      "total_assets": 3803253000,
      "total_equity": -17722887000,
      "total_liabilities": 21526140000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "999,988,028",
      "changes": "999,988,028",
      "date": "2025-04-17"
    },
    {
      "amount": "2,999,763,800",
      "changes": "2,999,763,800",
      "date": "2023-04-19"
    },
    {
      "amount": "2,999,763,800",
      "changes": "2,999,763,800",
      "date": "2023-04-19"
    },
    {
      "amount": "2,499,000,000",
      "changes": "2,499,000,000",
      "date": "2021-06-17"
    },
    {
      "amount": "2,499,000,000",
      "changes": "2,499,000,000",
      "date": "2021-06-17"
    }
  ],
  "main_products": "줄기세포치료제",
  "phone": "02-742-****",
  "years": [
    2024,
    2023,
    2022
  ]
}